Skip to main content
Premium Trial:

Request an Annual Quote

Linkage Biosciences Raises $2.1M in Series B Round

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Linkage Biosciences today announced it has raised $2.1 million in a Series B financing round.

The funds will be used to expand manufacturing capabilities, complete regulatory requirements in the US and Europe, and accelerate molecular tests to market, Zachary Antovich, CEO of Linkage, said in a statement.

Fisher Capital and Greenhouse Capital Partners led the round. All major existing investors, including Big Sky Partners, also were participants.

Linkage raised $2 million in a Series A round in 2009.

Based in San Francisco, Linkage's lead product is its LinkSeq HLA product line, which combines a proprietary software and chemistry platform along with real-time PCR instrumentation to provide "significant improvements in the analysis of complex genetic regions," such as an up-to 85 percent reduction in labor requirements, compared to current methods, Linkage said.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.